Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFTAROLINE for Endocarditis staphylococcal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 16 adverse event reports in the FDA FAERS database where CEFTAROLINE was used for Endocarditis staphylococcal.

Most Reported Side Effects for CEFTAROLINE

Side Effect Reports % Deaths Hosp.
Drug ineffective 70 21.7% 29 45
Acute kidney injury 39 12.1% 12 28
Off label use 33 10.3% 8 22
Toxic epidermal necrolysis 27 8.4% 23 19
Thrombocytopenia 22 6.8% 3 13
Treatment failure 22 6.8% 18 19
Neutropenia 18 5.6% 0 10
Pyrexia 18 5.6% 4 9
Rash 18 5.6% 0 6
Drug reaction with eosinophilia and systemic symptoms 17 5.3% 8 12
Stevens-johnson syndrome 15 4.7% 10 12
Staphylococcal bacteraemia 13 4.0% 9 10
Tubulointerstitial nephritis 13 4.0% 6 12
Agranulocytosis 12 3.7% 0 11
Blood creatinine increased 11 3.4% 3 9

Other Indications for CEFTAROLINE

Staphylococcal infection (56) Staphylococcal bacteraemia (42) Product used for unknown indication (31) Endocarditis (19) Pneumonia (14) Infection (13) Bacteraemia (12) Meningitis (11) Osteomyelitis (11) Antibiotic therapy (10)

Other Drugs Used for Endocarditis staphylococcal

DAPTOMYCIN (150) VANCOMYCIN (137) RIFAMPIN (72) GENTAMICIN (48) LINEZOLID (41) CEFAZOLIN (30) OXACILLIN (21) LEVOFLOXACIN (20) CUBICIN (19) CEFTAROLINE FOSAMIL (18)

Related Pages

CEFTAROLINE Full Profile All Endocarditis staphylococcal Drugs CEFTAROLINE Demographics CEFTAROLINE Timeline